newsfilter
← Latest News
GlobeNewswire·

Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress

-- Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast today at 8:00 a.m.